openPR Logo
Press release

Business overview and Growth Analysis on Antidiabetics market| Top Players: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company

01-04-2019 02:42 PM CET | Health & Medicine

Press release from: Global Market Insights Inc.

Antidiabetics market

Antidiabetics market

Global Antidiabetics Market is set to exceed USD 110 billion by 2024; according to a new research report by Global Market Insights.

Growing pervasiveness of diabetes worldwide will spur global antidiabetics market growth over the forecast timeframe. According to World Health Organization, in 2014, 422 million people suffered from diabetes mellitus, estimated to become the seventh death-leading cause by 2030. Thus, rising prevalence of the disease will lead to high adoption of antidiabetic drugs to control blood sugar as well as control disease complications. Moreover, accelerating number of obese/overweight people, pursuing unhealthy lifestyle habits is significantly increasing the risk of suffering from diabetes. Growing incidence of diabetes can be attributed to increasing obese population, thereby augmenting demand for antidiabetics in coming years.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/504

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• AstraZeneca
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Eli Lilly and Company
• Halozyme Therapeutics, Inc.
• Merck
• Novartis
• Novo Nordisk
• Oramed Pharmaceuticals Inc.
• Pfizer
• Sanofi

Insulin product segment is forecasted to progress at 12.3% CAGR over the projected period. With expanding patient population majorly suffering from type 2 diabetes, the need to administer insulin therapy will grow in the forthcoming years. Insulin is also used in combination with several oral drugs for better control of blood glucose. In addition, insulin also needs to be externally injected to patients with type 1 diabetes, that should impel segmental growth in coming period. Among several types of insulin, rapid acting analog insulin will show fastest growth over the forecast period.

Drug class product segment held 45.7% market share in 2017. DPP-IV drug class accounted for the largest revenue size in 2017 and will witness similar trend over the coming years. DPP-IV when combined with other antidiabetic agents are known to show positive effect on glucose control. These drugs show neutral effect on weight that further favours segmental growth. Development of new antidiabetic drugs including DPP-IV will boost segment growth in upcoming years.

Insulin pumps market will record highest CAGR of 11.3% during the projection timeframe. Insulin pump usage is recommended in patients having high resistance to insulin and weak glycaemic control. Insulin pumps prevent administration of multiple injections along with delivering high efficacy should escalate the customer preference. Availability of reimbursement in some countries will further accelerate demand for insulin pumps in the coming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/504

U.S. antidiabetics market held largest market share of 87.5% of North America antidiabetics market in 2017. High growth is attributable to elevating cases of diabetes along with robustly rising obese population. Majority of the adult population affected by diabetes mellitus are overweight or obese. Many firms across the U.S. are emphasizing on innovative diabetes medications. Also, growing awareness among the American population regarding diagnosis and treatment of target disease will boost demand for antidiabetics in future.

Antidiabetics Market, by Product
o Insulin
o Rapid acting analog
o Long acting analog
o Premixed insulin
o Short acting analog
o Intermediate acting insulin

o Drug class
o Alpha glucosidase inhibitors
o Biguanides
o Sulphonylureas
o GLP-1 (Glucagon like peptide) agonists
o DPP-IV (Dipeptidyl Peptidase) inhibitors
o Meglitinides
o SGLT-II (Sodium Glucose Transport Proteins) inhibitors
o Thiazolidinedione

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Business overview and Growth Analysis on Antidiabetics market| Top Players: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company here

News-ID: 1472141 • Views: 434

More Releases from Global Market Insights Inc.

Light Linear Alpha Olefin Market foreseen to grow exponentially over 2025 | By T …
The research report on Light Linear Alpha Olefin market offers a comprehensive view of this industry with every crucial detail subject to its overall stance in the global landscape and its applications in myriad sectors. The report also provides insight to distinguished factors that are expected to potentially fuel the growth path of the industry in the upcoming years, along with laying emphasis on minute details of the ongoing trends
COVID- 19 to Impact Demand Growth of Shotcrete Accelerator Market | By key playe …
The research report on Shotcrete Accelerator market offers a comprehensive view of this industry with every crucial detail subject to its overall stance in the global landscape and its applications in myriad sectors. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/2092 The report also provides insight to distinguished factors that are expected to potentially fuel the growth path of the industry in the upcoming years, along with laying emphasis on
COVID- 19 to Impact Demand Growth of Carbon Textile Reinforced Concrete Market | …
The research report on Carbon Textile Reinforced Concrete market offers a comprehensive view of this industry with every crucial detail subject to its overall stance in the global landscape and its applications in myriad sectors. The report also provides insight to distinguished factors that are expected to potentially fuel the growth path of the industry in the upcoming years, along with laying emphasis on minute details of the ongoing trends
Application in plastics to foster pigments market demand worldwide | By key play …
Selbyville, Delaware, According to a new research report by the market research and strategy consulting firm, Global Market Insights, Inc, Pigments Market size estimated over USD 14.86 billion in 2018 and to reach USD 21.8 billion by 2026. Endorsed by a massive end-user spectrum, the potential of pigments has been increasingly recognized by many chemical industry players. The wide requirement of corrosion inhibition and color imparting across various expanding

All 5 Releases


More Releases for Antidiabetics

US Antidiabetics Drug Market Outlook 2022 Report
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects Download Report Sample Weblink: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php For Report Sample Contact: neeraj@kuickresearch.com Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin
US Antidiabetics Drug Market Outlook 2022 Report Download
“US Antidiabetics Drug Market Outlook 2022” report gives clinical and non-clinical insight on trends associated with the development of Antidiabetics drug market in US. Report helps to identify the diabetes epidemiology (Prevalence of Type 1 and 2 Diabetes) in the US market along with the associated economic burden and productivity loss. “US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs
Antidiabetics Market Intelligence with Competitive Landscape 2023
The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally. The anti-diabetics market
Global Antidiabetics Drug Market Size - Industry Analysis And Forecast
Latest industry research report on: Global Antidiabetics Drug Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antidiabetics Drug in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1270897 Global Antidiabetics Drug market competition by top manufacturers, with production, price, revenue
US Antidiabetics Drug Market US Antidiabetics Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin 2.2 Historical En Route towards Oral Diabetic Medication Treatments Available for Diabetes Mellitus 3.1 Non-Pharmacological Approaches for Diabetes Mellitus 3.2 Pharmacological Approaches for Diabetes Mellitus Cataloguing of Antidiabetic Agents 4.1
US To Dominate Global Antidiabetics Drug Market
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Download Report: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin